ECHOSTAR CORP-A (E20.DE) Fundamental Analysis & Valuation

FRA:E20 • US2787681061

Current stock price

110.86 EUR
+2.78 (+2.57%)
Last:

This E20.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. E20.DE Profitability Analysis

1.1 Basic Checks

  • E20 had positive earnings in the past year.
  • In the past year E20 has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: E20 reported negative net income in multiple years.
  • Of the past 5 years E20 4 years had a positive operating cash flow.
E20.DE Yearly Net Income VS EBIT VS OCF VS FCFE20.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5B -10B

1.2 Ratios

  • With a Return On Assets value of -33.70%, E20 is not doing good in the industry: 86.36% of the companies in the same industry are doing better.
  • The Return On Equity of E20 (-251.43%) is worse than 86.36% of its industry peers.
Industry RankSector Rank
ROA -33.7%
ROE -251.43%
ROIC N/A
ROA(3y)-12.29%
ROA(5y)-6.56%
ROE(3y)-86.86%
ROE(5y)-50.67%
ROIC(3y)N/A
ROIC(5y)N/A
E20.DE Yearly ROA, ROE, ROICE20.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200 -250

1.3 Margins

  • E20 has a worse Gross Margin (25.82%) than 80.30% of its industry peers.
  • E20's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for E20 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.13%
GM growth 5Y-15.68%
E20.DE Yearly Profit, Operating, Gross MarginsE20.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. E20.DE Health Analysis

2.1 Basic Checks

  • E20 does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, E20 has more shares outstanding
  • The number of shares outstanding for E20 has been increased compared to 5 years ago.
  • E20 has a worse debt/assets ratio than last year.
E20.DE Yearly Shares OutstandingE20.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
E20.DE Yearly Total Debt VS Total AssetsE20.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • Based on the Altman-Z score of 0.65, we must say that E20 is in the distress zone and has some risk of bankruptcy.
  • E20's Altman-Z score of 0.65 is on the low side compared to the rest of the industry. E20 is outperformed by 68.18% of its industry peers.
  • A Debt/Equity ratio of 3.24 is on the high side and indicates that E20 has dependencies on debt financing.
  • The Debt to Equity ratio of E20 (3.24) is worse than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.24
Debt/FCF N/A
Altman-Z 0.65
ROIC/WACCN/A
WACC8.74%
E20.DE Yearly LT Debt VS Equity VS FCFE20.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B 20B 25B

2.3 Liquidity

  • A Current Ratio of 0.42 indicates that E20 may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.42, E20 is doing worse than 86.36% of the companies in the same industry.
  • A Quick Ratio of 0.38 indicates that E20 may have some problems paying its short term obligations.
  • E20 has a Quick ratio of 0.38. This is amonst the worse of the industry: E20 underperforms 89.39% of its industry peers.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.38
E20.DE Yearly Current Assets VS Current LiabilitesE20.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. E20.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 1628.89% over the past year.
  • The Earnings Per Share has been growing by 49.00% on average over the past years. This is a very strong growth
  • E20 shows a decrease in Revenue. In the last year, the revenue decreased by -5.18%.
  • The Revenue has been growing by 51.37% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1628.89%
EPS 3Y49%
EPS 5YN/A
EPS Q2Q%-441.46%
Revenue 1Y (TTM)-5.18%
Revenue growth 3Y95.83%
Revenue growth 5Y51.37%
Sales Q2Q%-4.31%

3.2 Future

  • Based on estimates for the next years, E20 will show a very negative growth in Earnings Per Share. The EPS will decrease by -15.91% on average per year.
  • E20 is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.25% yearly.
EPS Next Y-139.66%
EPS Next 2Y-41.63%
EPS Next 3Y-67.81%
EPS Next 5Y-15.91%
Revenue Next Year-3.41%
Revenue Next 2Y-2.74%
Revenue Next 3Y-2.61%
Revenue Next 5Y-0.25%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
E20.DE Yearly Revenue VS EstimatesE20.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B
E20.DE Yearly EPS VS EstimatesE20.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -10 -20 -30 -40

More info and screens

Find the best growth stocksShow best growing peers

1

4. E20.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 18.98 indicates a rather expensive valuation of E20.
  • E20's Price/Earnings ratio is in line with the industry average.
  • When comparing the Price/Earnings ratio of E20 to the average of the S&P500 Index (27.38), we can say E20 is valued slightly cheaper.
  • E20 is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 18.98
Fwd PE N/A
E20.DE Price Earnings VS Forward Price EarningsE20.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of E20 indicates a slightly more expensive valuation: E20 is more expensive than 77.27% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 39.9
E20.DE Per share dataE20.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • A cheap valuation may be justified as E20's earnings are expected to decrease with -67.81% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.63%
EPS Next 3Y-67.81%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. E20.DE Dividend Analysis

5.1 Amount

  • E20 does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

E20.DE Fundamentals: All Metrics, Ratios and Statistics

ECHOSTAR CORP-A

FRA:E20 (4/15/2026, 7:00:00 PM)

110.86

+2.78 (+2.57%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)03-02
Earnings (Next)05-07
Inst Owners98.44%
Inst Owner ChangeN/A
Ins Owners12.15%
Ins Owner ChangeN/A
Market Cap32.03B
Revenue(TTM)15.00B
Net Income(TTM)-14.50B
Analysts76.36
Price Target104.93 (-5.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)339.66%
Min EPS beat(2)-463.29%
Max EPS beat(2)1142.6%
EPS beat(4)2
Avg EPS beat(4)174.08%
Min EPS beat(4)-463.29%
Max EPS beat(4)1142.6%
EPS beat(8)3
Avg EPS beat(8)88.21%
EPS beat(12)6
Avg EPS beat(12)20.43%
EPS beat(16)8
Avg EPS beat(16)28.88%
Revenue beat(2)0
Avg Revenue beat(2)-3.28%
Min Revenue beat(2)-5.46%
Max Revenue beat(2)-1.09%
Revenue beat(4)0
Avg Revenue beat(4)-3.22%
Min Revenue beat(4)-5.46%
Max Revenue beat(4)-1.09%
Revenue beat(8)0
Avg Revenue beat(8)-2.77%
Revenue beat(12)1
Avg Revenue beat(12)21.02%
Revenue beat(16)4
Avg Revenue beat(16)16.06%
PT rev (1m)3.7%
PT rev (3m)36.29%
EPS NQ rev (1m)-22.39%
EPS NQ rev (3m)17.17%
EPS NY rev (1m)25.98%
EPS NY rev (3m)22.69%
Revenue NQ rev (1m)-0.83%
Revenue NQ rev (3m)-0.16%
Revenue NY rev (1m)-0.83%
Revenue NY rev (3m)-0.59%
Valuation
Industry RankSector Rank
PE 18.98
Fwd PE N/A
P/S 2.51
P/FCF N/A
P/OCF N/A
P/B 6.54
P/tB 6.61
EV/EBITDA 39.9
EPS(TTM)5.84
EY5.27%
EPS(NY)-2.32
Fwd EYN/A
FCF(TTM)-3.13
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS44.09
BVpS16.94
TBVpS16.78
PEG (NY)N/A
PEG (5Y)N/A
Graham Number47.1841 (-57.44%)
Profitability
Industry RankSector Rank
ROA -33.7%
ROE -251.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.82%
FCFM N/A
ROA(3y)-12.29%
ROA(5y)-6.56%
ROE(3y)-86.86%
ROE(5y)-50.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.13%
GM growth 5Y-15.68%
F-Score3
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 3.24
Debt/FCF N/A
Debt/EBITDA 12.49
Cap/Depr 60.91%
Cap/Sales 6.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.38
Altman-Z 0.65
F-Score3
WACC8.74%
ROIC/WACCN/A
Cap/Depr(3y)111.73%
Cap/Depr(5y)101.51%
Cap/Sales(3y)11.48%
Cap/Sales(5y)15.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1628.89%
EPS 3Y49%
EPS 5YN/A
EPS Q2Q%-441.46%
EPS Next Y-139.66%
EPS Next 2Y-41.63%
EPS Next 3Y-67.81%
EPS Next 5Y-15.91%
Revenue 1Y (TTM)-5.18%
Revenue growth 3Y95.83%
Revenue growth 5Y51.37%
Sales Q2Q%-4.31%
Revenue Next Year-3.41%
Revenue Next 2Y-2.74%
Revenue Next 3Y-2.61%
Revenue Next 5Y-0.25%
EBIT growth 1Y70.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year127.76%
EBIT Next 3Y32.04%
EBIT Next 5Y18.28%
FCF growth 1Y-263.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-107.93%
OCF growth 3YN/A
OCF growth 5YN/A

ECHOSTAR CORP-A / E20.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ECHOSTAR CORP-A (E20.DE) stock?

ChartMill assigns a fundamental rating of 1 / 10 to E20.DE.


What is the valuation status of ECHOSTAR CORP-A (E20.DE) stock?

ChartMill assigns a valuation rating of 1 / 10 to ECHOSTAR CORP-A (E20.DE). This can be considered as Overvalued.


Can you provide the profitability details for ECHOSTAR CORP-A?

ECHOSTAR CORP-A (E20.DE) has a profitability rating of 1 / 10.


Can you provide the financial health for E20 stock?

The financial health rating of ECHOSTAR CORP-A (E20.DE) is 0 / 10.


Can you provide the expected EPS growth for E20 stock?

The Earnings per Share (EPS) of ECHOSTAR CORP-A (E20.DE) is expected to decline by -139.66% in the next year.